Immunocore Holdings plc - ADR (IMCR)

CUSIP: 45258D105

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / ADR
Shares outstanding
50,698,400
Total 13F shares
47,759,431
Share change
+496,857
Total reported value
$1,498,675,257
Put/Call ratio
398%
Price per share
$31.38
Number of holders
132
Value change
+$17,984,702
Number of buys
76
Number of sells
52

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 45258D105?
CUSIP 45258D105 identifies IMCR - Immunocore Holdings plc - ADR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of IMCR - Immunocore Holdings plc - ADR (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
T. Rowe Price Investment Management, Inc.
13F
Company
14%
7,051,818
$209,228,000 31 Mar 2025
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
12%
6,131,720
$181,928,132 31 Mar 2025
13F
RTW INVESTMENTS, LP
13F
Company
9.6%
4,869,798
$144,486,907 31 Mar 2025
13F
FMR LLC
13F
Company
9.5%
4,840,496
$143,617,509 31 Mar 2025
13F
Jallal Bahija
13D/G
8.2%
4,493,139
$135,513,072 $0 31 Dec 2024
PRIMECAP MANAGEMENT CO/CA/
13D/G 13F
Company
7.5%
3,772,234
$130,443,852 +$38,165,393 30 Jun 2025
BAKER BROS. ADVISORS LP
13F 3/4/5
Company · Director
4.6%
2,322,656
$68,913,204 31 Mar 2025
TANG CAPITAL MANAGEMENT LLC
13F
Company
3.8%
1,915,708
$56,839,056 31 Mar 2025
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
3.7%
1,887,940
$56,016,000 31 Mar 2025
13F
Kynam Capital Management, LP
13F
Company
3.3%
1,695,576
$50,307,740 31 Mar 2025
13F
Deep Track Capital, LP
13F
Company
2.8%
1,411,402
$41,876,297 31 Mar 2025
13F
GENERAL ATLANTIC, L.P.
13F
Individual
2.5%
1,261,684
$37,434,164 31 Mar 2025
13F
Bellevue Group AG
13F
Company
2.4%
1,221,794
$36,250,628 31 Mar 2025
13F
ARMISTICE CAPITAL, LLC
13F
Company
1.9%
978,000
$29,017,260 31 Mar 2025
13F
Fiera Capital Corp
13F
Company
1.6%
805,150
$23,888,801 31 Mar 2025
13F
CITIGROUP INC
13F
Company
1.3%
639,288
$18,967,675 31 Mar 2025
13F
Point72 Asset Management, L.P.
13F
Company
1.2%
628,292
$18,641,424 31 Mar 2025
13F
TWO SIGMA ADVISERS, LP
13F
Company
1%
523,400
$15,529,278 31 Mar 2025
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.94%
478,864
$14,207,895 31 Mar 2025
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
0.91%
460,751
$13,670,482 31 Mar 2025
13F
Hudson Bay Capital Management LP
13F
Company
0.78%
395,334
$11,729,560 31 Mar 2025
13F
Woodline Partners LP
13F
Company
0.65%
328,245
$9,739,029 31 Mar 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.6%
305,364
$9,060,150 31 Mar 2025
13F
Frazier Life Sciences Management, L.P.
13F
Company
0.59%
301,170
$8,935,714 31 Mar 2025
13F
TD ASSET MANAGEMENT INC
13F
Company
0.58%
295,854
$8,777,988 31 Mar 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.58%
295,408
$8,764,755 31 Mar 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.56%
285,270
$8,463,961 31 Mar 2025
13F
BlackRock, Inc.
13F
Company
0.44%
225,545
$6,691,920 31 Mar 2025
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.4%
202,806
$6,017,254 31 Mar 2025
13F
UBS Group AG
13F
Company
0.35%
176,132
$5,225,837 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
0.34%
173,861
$5,158,455 31 Mar 2025
13F
BNP Paribas Asset Management Holding S.A.
13F
Company
0.32%
161,292
$4,785,000 31 Mar 2025
13F
Legal & General Group Plc
13F
Company
0.28%
141,675
$4,203,497 31 Mar 2025
13F
S.c.a. Candriam
13F
Individual
0.27%
134,785
$3,999,069 31 Mar 2025
13F
Jefferies Financial Group Inc.
13F
Company
0.22%
110,101
$3,266,697 31 Mar 2025
13F
BARCLAYS PLC
13F
Company
0.21%
107,090
$3,177,361 31 Mar 2025
13F
CANTOR FITZGERALD, L. P.
13F
Individual
0.2%
100,000
$2,967,000 31 Mar 2025
13F
DIADEMA PARTNERS LP
13F
Company
0.19%
96,984
$2,877,515 31 Mar 2025
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.19%
94,919
$2,816,247 31 Mar 2025
13F
AXA S.A.
13F
Company
0.19%
94,762
$2,811,589 31 Mar 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.18%
90,570
$2,687,212 31 Mar 2025
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.17%
83,670
$2,482,489 31 Mar 2025
13F
STATE STREET CORP
13F
Company
0.16%
81,159
$2,407,988 31 Mar 2025
13F
Cubist Systematic Strategies, LLC
13F
Company
0.14%
68,629
$2,036,222 31 Mar 2025
13F
ENVESTNET ASSET MANAGEMENT INC
13F
Company
0.13%
67,259
$1,995,575 31 Mar 2025
13F
SCHRODER INVESTMENT MANAGEMENT GROUP
13F
Company
0.13%
65,539
$1,938,644 31 Mar 2025
13F
Hennion & Walsh Asset Management, Inc.
13F
Company
0.12%
62,555
$1,856,007 31 Mar 2025
13F
TUDOR INVESTMENT CORP ET AL
13F
Company
0.11%
54,493
$1,616,807 31 Mar 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.11%
53,636
$1,591,380 31 Mar 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.1%
52,662
$1,562,482 31 Mar 2025
13F

Institutional Holders of Immunocore Holdings plc - ADR (IMCR) as of Q2 2025

As of 30 Jun 2025, Immunocore Holdings plc - ADR (IMCR) was held by 132 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 47,759,431 shares. The largest 10 holders included T. Rowe Price Investment Management, Inc., RTW INVESTMENTS, LP, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, PRIMECAP MANAGEMENT CO/CA/, Bellevue Group AG, BAKER BROS. ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, Deep Track Capital, LP, and BVF INC/IL. This page lists 133 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
115
Q2 2025 holders
132
Holder diff
17
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.